Login

The Investor on Tour - Q&A with Francis Van Eeckhout, CEO Deceuninck | Francis Van Eeckhout - CEO of Deceuninck 00:10:00

Share On Facebook Share On Twitter

Francis Van Eeckhout is Chairman/Interim CEO at Deceuninck.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Green Automotive Company: Strategic Updates and Future Growth with CEO Ian Hobday
00:10:00
Interview with Murray Hill, Managing Director and CEO of Elevate Uranium Limited
00:10:00
The Maverick in vip aircraft mods|Jesus Diaz, Director,Liberty Partners
00:10:00
Nerd Word: Correlation Insights with Alex Kluesner | Alex Kluesner - Investment Strategy Manager of Buckingham Strategic Wealth
00:10:00
Revolutionizing Commercial Real Estate Investment Through Innovative Technology and Secure Bond Offerings | Falk Raudies , CEO, FCR Immobilien AG.
00:10:00
Interview with Don Ranta, CEO of Rare Element Resources on Rare Earth Market Trends and Company Prospects
00:10:00
Tax Secrets Your Preparer Won't Reveal with HG Thomas | HG Thomas - Founder of HG Thomas Wealth Management
00:10:00
Pegatron Corp. experiences a significant increase from just 1% in 2021, noted in relation to #appleindia.
00:10:00
Unbound Group's Strategic Vision and Financial Outlook with Ian Watson and Dan Lampard | Ian Watson, CEO, Unbound Group PLC.
00:10:00
Roger Ailes: Revolutionizing American Cable News|Roger Ailes
00:10:00
Jean Hynes of Wellington Management on Healthcare Investing: Insights on Medical Advances, Collaborative Culture, and the Future of the Sector
00:10:00
CEO of BacTech Ross Orr Talks About Corporate Highlights and Ecuador's Presidential Election | Ross Orr , President & CEO, BacTech Environmental Corp. (IE)

© 2026 Nehu